Furthermore, consistent with the fact that the miR-183/96/182 cluster directly targets SMAD4 and FOXO3, they observed a significant increase in the levels of SMAD4 and FOXO3 following avenanthramide C treatment in colon cancer cells. The gene discussed is FOXO3; the disease is malignant colon neoplasm.